Revolutionary Treatments for Addiction
Addiction is one of the world’s biggest unmet medical needs. Substance and behavioural addictions affect over 1.3¹ billion people worldwide. Yet all current treatments have high failure rates.
Awakn is developing a better solution to treat addiction: psychedelic therapeutics – drugs and therapies used in combination. We are a biotech company researching, developing and commercializing these therapeutics.
Through clinical trials, our team has shown that this approach has the potential to be more effective than any addiction treatment currently available. We now aspire to become the market leader in effective addiction treatment, meeting a vast global need that is failed by current approaches.